During the past decade, Palo Alto Medical Foundation-Sunnyvale conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 52 clinical trials were completed, i.e. on average, 54.2% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 47 clinical trials were completed. i.e. 162.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palo Alto Medical Foundation-Sunnyvale" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "NRG Oncology" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation-Sunnyvale" #1 collaborator was "National Cancer Institute (NCI)" with 64 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation-Sunnyvale" are "Invasive Breast Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Ovarian Seromucinous Carcinoma" (6 trials) and "Recurrent Fallopian Tube Carcinoma" (6 trials). Many other conditions were trialed in "Palo Alto Medical Foundation-Sunnyvale" in a lesser frequency.

Most popular intervention types in "Palo Alto Medical Foundation-Sunnyvale" are "Drug" (112 trials), "Other" (84 trials), "Biological" (51 trials), "Procedure" (35 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (38 trials), "Computed Tomography" (21 trials), "Questionnaire Administration" (19 trials) and "Biospecimen Collection" (17 trials). Other intervention names were less common.

The vast majority of trials in "Palo Alto Medical Foundation-Sunnyvale" are 101 trials for "All" genders, 30 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Palo Alto Medical Foundation-Sunnyvale". undefined are not yet recruiting, 31 are recruiting, 76 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Palo Alto Medical Foundation-Sunnyvale, 3 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Palo Alto Medical Foundation-Sunnyvale, 3 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".